Search Results - "Tanuma, J."

Response to Letter to the Editor “Ectomesenchymal chondromyxoid tumour on the lateral border of the tongue: some historical and clinical considerations” by Sakurai, K., Nakamori, K., Yamazaki, M., Tanuma, J.-i.

Get full text

An ectomesenchymal chondromyxoid tumour on the lateral border of the tongue by Sakurai, K., Nakamori, K., Yamazaki, M., Tanuma, J.-I.

“…Ectomesenchymal chondromyxoid tumour (ECT) is an extremely rare intraoral mesenchymal tumour. Most of these tumours have been identified on the anterior aspect…”
Get full text

Corrigendum to “An ectomesenchymal chondromyxoid tumour on the lateral border of the tongue” [Int J Oral Maxillofac Surg 49 (2020) 1290–1203] by Sakurai, K., Nakamori, K., Yamazaki, M., Tanuma, J.-I.

Get full text

Nightlife clusters of coronavirus disease in Tokyo between March and April 2020 by Takaya, S., Tsuzuki, S., Hayakawa, K., Kawashima, A., Okuhama, A., Kanda, K., Suzuki, T., Akiyama, Y., Miyazato, Y., Ide, S., Nakamura, K., Nomoto, H., Nakamoto, T., Hikida, S., Tanuma, J., Ohara, K., Ito, T., Baba, T., Yamamoto, K., Ujiie, M., Saito, S., Morioka, S., Ishikane, M., Kinoshita, N., Kutsuna, S., Ohmagari, N.

“…We analysed associations between exposure to nightlife businesses and severe acute respiratory syndrome coronavirus 2 PCR test results at a tertiary hospital…”
Get full text

Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias by Takeda, T., Sugihara, K., Hirayama, Y., Hirano, M., Tanuma, J-I., Semba, I.

“…Background:  Oral squamous cell carcinoma develops through a multistep of genetic mutations, and the process can be morphologically recognized as oral…”
Get full text

Cardiovascular disease‐related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD) by Bijker, R, Jiamsakul, A, Uy, E, Kumarasamy, N, Ditango, R, Chaiwarith, R, Wong, WW, Avihingsanon, A, Sun, LP, Yunihastuti, E, Pujari, S, Do, CD, Merati, TP, Kantipong, P, Nguyen, KV, Kamarulzaman, A, Zhang, F, Lee, MP, Choi, JY, Tanuma, J, Ng, OT, Sim, BLH, Ross, J, Kiertiburanakul, S, Ly, P. S., Ditangco, R, Cuong, DD, Sohn, AH, Law, MG, Jiamsakul, A

“…Objectives With aging of the HIV‐positive population, cardiovascular disease (CVD) increasingly contributes to morbidity and mortality. We investigated…”
Get full text

Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV by Han, WM, Jiamsakul, A, Jantarapakde, J, Yunihastuti, E, Choi, JY, Ditangco, R, Chaiwarith, R, Sun, LP, Khusuwan, S, Merati, TP, Do, CD, Azwa, I, Lee, M‐P, Van Nguyen, K, Chan, Y‐J, Kiertiburanakul, S, Ng, OT, Tanuma, J, Pujari, S, Zhang, F, Gani, YM, Sangle, S, Ross, J, Kumarasamy, N

“…Objectives We conducted a longitudinal cohort analysis to evaluate the association of pre‐treatment body mass index (BMI) with CD4 recovery, virological…”
Get full text

Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia‐Pacific by Rupasinghe, D, Kiertiburanakul, S, Kamarulzaman, A, Zhang, F, Kumarasamy, N, Chaiwarith, R, Merati, TP, Do, CD, Khusuwan, S, Avihingsanon, A, Lee, MP, Ly, PS, Yunihastuti, E, Nguyen, KV, Ditangco, R, Chan, YJ, Pujari, S, Ng, OT, Choi, JY, Sim, BLH, Tanuma, J, Sangle, S, Ross, J, Law, M

“…Objectives Early mortality among those still initiating antiretroviral therapy (ART) with advanced stages of HIV infection in resource‐limited settings remains…”
Get full text

Clinical Significance of High Anti-Entamoeba histolytica Antibody Titer in Asymptomatic HIV-1-infected Individuals by Watanabe, Koji, Aoki, Takahiro, Nagata, Naoyoshi, Tanuma, Junko, Kikuchi, Yoshimi, Oka, Shinichi, Gatanaga, Hiroyuki

“…Background. Anti-Entamoeba histolytica antibody (anti-E. histolytica) is widely used in seroprevalence studies though its clinical significance has not been…”
Get full text

Long‐term loss to follow‐up in the TREAT Asia HIV Observational Database (TAHOD) by Jiamsakul, A, Kiertiburanakul, S, Ng, OT, Chaiwarith, R, Wong, W, Ditangco, R, Nguyen, KV, Avihingsanon, A, Pujari, S, Do, CD, Lee, M‐P, Ly, PS, Yunihastuti, E, Kumarasamy, N, Kamarulzaman, A, Tanuma, J, Zhang, F, Choi, JY, Kantipong, P, Sim, BLH, Ross, J, Law, M, Merati, TP, Ly, P. S., Khol, V., Zhang, F. J., Zhao, H. X., Han, N., Lee, M. P., Li, P. C. K., Lam, W., Chan, Y. T., Kumarasamy, N., Saghayam, S., Ezhilarasi, C., Pujari, S., Joshi, K., Gaikwad, S., Chitalikar, A., Sangle, S., Mave, V., Marbaniang, I., Merati, T. P., Wirawan, D. N., Yuliana, F., Yunihastuti, E., Imran, D., Widhani, A., Tanuma, J., Oka, S., Nishijima, T., Choi, J. Y., Na, S., Kim, J. M., Sim, B. L. H., Gani, Y. M., Rudi, N. B., Kamarulzaman, A., Syed Omar, S. F., Ponnampalavanar, S., Azwa, I., Ditangco, R., Pasayan, M. K., Mationg, M. L., Wong, W. W., Ku, W. W., Wu, P. C., Ng, O. T., Lim, P. L., Lee, L. S., Ferdous, Z., vihingsanon, A., Gatechompol, S., Phanuphak, P., Phadungphon, C., Kiertiburanakul, S., Phuphuakrat, A., Chumla, L., Sanmeema, N., Chaiwarith, R., Sirisanthana, T., Kotarathititum, W., Praparattanapan, J., Khusuwan, S., Nguyen, K. V., Bui, H. V., Nguyen, D. T. H., Nguyen, D. T., Do, C. D., Ngo, A. V., Nguyen, L. T., Sohn, A. H., Ross, L., Petersen, B., Law, M. G., Jiamsakul, A., Rupasinghe, D.

“…Objectives With earlier antiretroviral therapy (ART) initiation, time spent in HIV care is expected to increase. We aimed to investigate loss to follow‐up…”
Get full text

Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia by Boettiger, DC, Law, MG, Ross, J, Huy, BV, Heng, BSL, Ditangco, R, Kiertiburanakul, S, Avihingsanon, A, Cuong, DD, Kumarasamy, N, Kamarulzaman, A, Ly, PS, Yunihastuti, E, Parwati Merati, T, Zhang, F, Khusuwan, S, Chaiwarith, R, Lee, MP, Sangle, S, Choi, JY, Ku, WW, Tanuma, J, Ng, OT, Sohn, AH, Wester, CW, Nash, D, Mugglin, C, Pujari, S

“…Objectives: Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs)…”
Get full text

Effects of unplanned treatment interruptions on HIV treatment failure – results from TAHOD by Jiamsakul, Awachana, Kerr, Stephen J., Ng, Oon Tek, Lee, Man Po, Chaiwarith, Romanee, Yunihastuti, Evy, Van Nguyen, Kinh, Pham, Thuy Thanh, Kiertiburanakul, Sasisopin, Ditangco, Rossana, Saphonn, Vonthanak, Sim, Benedict L. H., Merati, Tuti Parwati, Wong, Wingwai, Kantipong, Pacharee, Zhang, Fujie, Choi, Jun Yong, Pujari, Sanjay, Kamarulzaman, Adeeba, Oka, Shinichi, Mustafa, Mahiran, Ratanasuwan, Winai, Petersen, Boondarika, Law, Matthew, Kumarasamy, Nagalingeswaran, Mean, CV, Khol, V, Zhao, HX, Han, N, Li, PCK, Lam, W, Chan, YT, Saghayam, S, Ezhilarasi, C, Joshi, K, Gaikwad, S, Chitalikar, A, Wirawan, DN, Yuliana, F, Imran, D, Widhani, A, Tanuma, J, Nishijima, T, Na, S, Kim, JM, Gani, YM, David, R, Omar, SF Syed, Ponnampalavanar, S, Azwa, I, Nordin, N, Uy, E, Bantique, R, Ku, WW, Wu, PC, Lim, PL, Lee, LS, Ohnmar, PS, Ruxrungtham, K, Avihingsanon, A, Chusut, P, Sungkanuparph, S, Chumla, L, Sanmeema, N, Sirisanthana, T, Kotarathititum, W, Praparattanapan, J, Kambua, P, Sriondee, R, Bui, VH, Nguyen, THD, Cuong, DD, Ha, HL, Sohn, AH, Durier, N, Petersen, B, Jiamsakul, A, Boettiger, DC

“…Objectives Treatment interruptions (TIs) of combination antiretroviral therapy (cART) are known to lead to unfavourable treatment outcomes but do still occur…”
Get full text

Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti‐tuberculosis treatment in HIV/tuberculosis‐coinfected patients: results from the TREAT Asia HIV Observational Database by Han, SH, Zhou, J, Lee, MP, Zhao, H, Chen, Y‐MA, Kumarasamy, N, Pujari, S, Lee, C, Omar, SFS, Ditangco, R, Phanuphak, N, Kiertiburanakul, S, Chaiwarith, R, Merati, TP, Yunihastuti, E, Tanuma, J, Saphonn, V, Sohn, AH, Choi, JY

“…Objectives We evaluated the effect of the time interval between the initiation of antiretroviral therapy (ART) and the initiation of tuberculosis (TB)…”
Get full text

Raltegravir can be used safely in HIV-1-infected patients treated with warfarin by Honda, H, Gatanaga, H, Aoki, T, Watanabe, K, Yazaki, H, Tanuma, J, Tsukada, K, Honda, M, Teruya, K, Kikuchi, Y, Oka, S

“…Drug co-administration often affects the patient response to warfarin through various mechanisms. We describe here five HIV-1-infected patients on treatment…”
Get more information

Pleomorphic adenoma presenting low T 2 signal-intensity on magnetic resonance imaging by Indo, H, Suenaga, S, Nozoe, E, Nakamura, N, Tanuma, J, Semba, I, Majima, HJ

Get full text

Pleomorphic adenoma presenting low T2 signal-intensity on magnetic resonance imaging by Indo, H, Suenaga, S, Nozoe, E, Nakamura, N, Tanuma, J, Semba, I, Majima, H J

“…We report an unusual case of pleomorphic adenoma of the submandibular gland in a 48-year-old female. The present case appeared as a relatively homogeneous, low…”
Get full text

Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134 by Kanbara, K, Sato, S, Tanuma, J, Tamamura, H, Gotoh, K, Yoshimori, M, Kanamoto, T, Kitano, M, Fujii, N, Nakashima, H

“…The chemokine receptors CXCR4 and CCR5 are considered to be potential targets for the inhibition of HIV-1 replication. We have reported that T134 and T140…”
Get more information

Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat by TANUMA, J.-I, SHISA, H, HIAI, H, HIGASHI, S, YAMADA, Y, KAMOTO, T, HIRAYAMA, Y, MATSUUCHI, H, KITANO, M

“…The incidence of tongue carcinomas (TCs) induced by oral administration of 4-nitroquinoline 1-oxide in rats is strain dependent. The inbred Dark-Agouti (DA)…”
Get full text

Propylnitrosourea-induced T-lymphomas in LEXF RI strains of rats: genetic analysis by LU, L.-M, SHISA, H, TANUMA, J.-I, HIAL, H

“…Oral administration of propylnitrosourea (PNU) in drinking water induces high incidence of lympho-haemopoietic malignancies in rats. Previously we reported…”
Get full text

Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study by Romo, Matthew L, Patel, Rena C, Edwards, Jessie K, Humphrey, John M, Musick, Beverly S, Bernard, Caitlin, Maina, Mercy W, Brazier, Ellen, Castelnuovo, Barbara, Penner, Jeremy, Wyka, Katarzyna, Cardoso, Sandra Wagner, Ly, Penh Sun, Kunzekwenyika, Cordelia, Cortés, Claudia P, Panczak, Radoslaw, Kelvin, Elizabeth A, Wools-Kaloustian, Kara K, Nash, Denis

“…The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middle-income countries (LMICs) was complicated by an initial safety signal…”
Get full text